nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A4—Temozolomide—brain cancer	0.116	0.387	CbGbCtD
Nimodipine—CYP3A4—Lomustine—brain cancer	0.0988	0.329	CbGbCtD
Nimodipine—CYP3A5—Etoposide—brain cancer	0.0612	0.204	CbGbCtD
Nimodipine—CACNA1D—cochlea—brain cancer	0.0309	0.0803	CbGeAlD
Nimodipine—CACNA1D—internal ear—brain cancer	0.0293	0.0761	CbGeAlD
Nimodipine—CACNB4—ganglion—brain cancer	0.0273	0.0709	CbGeAlD
Nimodipine—CYP3A4—Etoposide—brain cancer	0.0239	0.0796	CbGbCtD
Nimodipine—Vasospasm—Carmustine—brain cancer	0.0134	0.047	CcSEcCtD
Nimodipine—Phlebitis—Carboplatin—brain cancer	0.0111	0.039	CcSEcCtD
Nimodipine—CACNB4—telencephalon—brain cancer	0.0105	0.0274	CbGeAlD
Nimodipine—CACNA1F—head—brain cancer	0.00996	0.0259	CbGeAlD
Nimodipine—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00961	0.0338	CcSEcCtD
Nimodipine—Platelet count decreased—Hydroxyurea—brain cancer	0.0095	0.0334	CcSEcCtD
Nimodipine—CACNB1—telencephalon—brain cancer	0.0084	0.0218	CbGeAlD
Nimodipine—CACNB4—medulla oblongata—brain cancer	0.00826	0.0215	CbGeAlD
Nimodipine—CACNB3—telencephalon—brain cancer	0.00806	0.021	CbGeAlD
Nimodipine—NR3C2—hindbrain—brain cancer	0.00781	0.0203	CbGeAlD
Nimodipine—CACNB4—midbrain—brain cancer	0.00755	0.0196	CbGeAlD
Nimodipine—CACNB4—spinal cord—brain cancer	0.00737	0.0192	CbGeAlD
Nimodipine—Deep vein thrombosis—Temozolomide—brain cancer	0.00725	0.0255	CcSEcCtD
Nimodipine—CACNB1—medulla oblongata—brain cancer	0.0066	0.0172	CbGeAlD
Nimodipine—CACNB3—pituitary gland—brain cancer	0.00656	0.0171	CbGeAlD
Nimodipine—CACNB4—head—brain cancer	0.00655	0.017	CbGeAlD
Nimodipine—CACNB3—medulla oblongata—brain cancer	0.00633	0.0165	CbGeAlD
Nimodipine—CACNB1—midbrain—brain cancer	0.00603	0.0157	CbGeAlD
Nimodipine—CACNB4—central nervous system—brain cancer	0.00598	0.0155	CbGeAlD
Nimodipine—AHR—telencephalon—brain cancer	0.00597	0.0155	CbGeAlD
Nimodipine—CACNB1—spinal cord—brain cancer	0.00588	0.0153	CbGeAlD
Nimodipine—CACNB4—cerebellum—brain cancer	0.00584	0.0152	CbGeAlD
Nimodipine—CACNB3—midbrain—brain cancer	0.00578	0.015	CbGeAlD
Nimodipine—CACNB2—telencephalon—brain cancer	0.00541	0.0141	CbGeAlD
Nimodipine—CACNB1—head—brain cancer	0.00523	0.0136	CbGeAlD
Nimodipine—CACNB3—head—brain cancer	0.00502	0.013	CbGeAlD
Nimodipine—AHR—pituitary gland—brain cancer	0.00486	0.0126	CbGeAlD
Nimodipine—CACNB1—central nervous system—brain cancer	0.00477	0.0124	CbGeAlD
Nimodipine—CACNB4—brain—brain cancer	0.00475	0.0123	CbGeAlD
Nimodipine—CACNA1D—telencephalon—brain cancer	0.00473	0.0123	CbGeAlD
Nimodipine—AHR—medulla oblongata—brain cancer	0.00469	0.0122	CbGeAlD
Nimodipine—CACNB1—cerebellum—brain cancer	0.00467	0.0121	CbGeAlD
Nimodipine—CACNB3—central nervous system—brain cancer	0.00458	0.0119	CbGeAlD
Nimodipine—NR3C2—brainstem—brain cancer	0.00448	0.0116	CbGeAlD
Nimodipine—CACNB3—cerebellum—brain cancer	0.00448	0.0116	CbGeAlD
Nimodipine—Sweating increased—Procarbazine—brain cancer	0.00446	0.0157	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00441	0.0155	CcSEcCtD
Nimodipine—CACNB2—pituitary gland—brain cancer	0.00441	0.0115	CbGeAlD
Nimodipine—CACNA1C—telencephalon—brain cancer	0.00437	0.0114	CbGeAlD
Nimodipine—AHR—midbrain—brain cancer	0.00429	0.0111	CbGeAlD
Nimodipine—AHR—spinal cord—brain cancer	0.00418	0.0109	CbGeAlD
Nimodipine—Clevidipine—CYP2C9—brain cancer	0.00402	0.21	CrCbGaD
Nimodipine—Thrombocytopenia—Lomustine—brain cancer	0.00402	0.0141	CcSEcCtD
Nimodipine—Jaundice—Procarbazine—brain cancer	0.00398	0.014	CcSEcCtD
Nimodipine—NR3C2—telencephalon—brain cancer	0.00397	0.0103	CbGeAlD
Nimodipine—CACNA1D—pituitary gland—brain cancer	0.00385	0.01	CbGeAlD
Nimodipine—Phlebitis—Carmustine—brain cancer	0.00385	0.0135	CcSEcCtD
Nimodipine—CACNB1—brain—brain cancer	0.00379	0.00986	CbGeAlD
Nimodipine—AHR—endocrine gland—brain cancer	0.00376	0.00979	CbGeAlD
Nimodipine—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00368	0.013	CcSEcCtD
Nimodipine—CACNB3—brain—brain cancer	0.00363	0.00945	CbGeAlD
Nimodipine—Nilvadipine—CYP2C9—brain cancer	0.00361	0.189	CrCbGaD
Nimodipine—CACNA1C—pituitary gland—brain cancer	0.00356	0.00925	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Etoposide—brain cancer	0.00353	0.0124	CcSEcCtD
Nimodipine—Flushing—Procarbazine—brain cancer	0.0034	0.012	CcSEcCtD
Nimodipine—CACNB2—head—brain cancer	0.00337	0.00876	CbGeAlD
Nimodipine—Hyponatraemia—Carmustine—brain cancer	0.00333	0.0117	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00332	0.0117	CcSEcCtD
Nimodipine—AHR—cerebellum—brain cancer	0.00332	0.00862	CbGeAlD
Nimodipine—NR3C2—pituitary gland—brain cancer	0.00324	0.00842	CbGeAlD
Nimodipine—NR3C2—medulla oblongata—brain cancer	0.00312	0.00812	CbGeAlD
Nimodipine—Amlodipine—CYP2C9—brain cancer	0.00311	0.162	CrCbGaD
Nimodipine—CACNB2—central nervous system—brain cancer	0.00308	0.008	CbGeAlD
Nimodipine—Liver function test abnormal—Carmustine—brain cancer	0.00306	0.0108	CcSEcCtD
Nimodipine—CACNB2—cerebellum—brain cancer	0.00301	0.00782	CbGeAlD
Nimodipine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00299	0.0105	CcSEcCtD
Nimodipine—CACNA1D—endocrine gland—brain cancer	0.00298	0.00776	CbGeAlD
Nimodipine—Phlebitis—Etoposide—brain cancer	0.00298	0.0105	CcSEcCtD
Nimodipine—Anaemia—Procarbazine—brain cancer	0.00295	0.0104	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00295	0.0104	CcSEcCtD
Nimodipine—CACNA1D—head—brain cancer	0.00295	0.00766	CbGeAlD
Nimodipine—Felodipine—CYP2C9—brain cancer	0.00287	0.15	CrCbGaD
Nimodipine—NR3C2—midbrain—brain cancer	0.00285	0.00742	CbGeAlD
Nimodipine—Cardiac failure congestive—Etoposide—brain cancer	0.00283	0.00994	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00283	0.00994	CcSEcCtD
Nimodipine—NR3C2—spinal cord—brain cancer	0.00278	0.00724	CbGeAlD
Nimodipine—Nifedipine—CYP2C9—brain cancer	0.00278	0.145	CrCbGaD
Nimodipine—Hypertension—Procarbazine—brain cancer	0.00276	0.00969	CcSEcCtD
Nimodipine—CACNA1C—endocrine gland—brain cancer	0.00275	0.00716	CbGeAlD
Nimodipine—Nicardipine—CYP2C9—brain cancer	0.00273	0.143	CrCbGaD
Nimodipine—CACNA1C—head—brain cancer	0.00272	0.00707	CbGeAlD
Nimodipine—Myalgia—Procarbazine—brain cancer	0.00272	0.00956	CcSEcCtD
Nimodipine—Sweating increased—Temozolomide—brain cancer	0.0027	0.00949	CcSEcCtD
Nimodipine—AHR—brain—brain cancer	0.00269	0.007	CbGeAlD
Nimodipine—CACNA1D—central nervous system—brain cancer	0.00269	0.00699	CbGeAlD
Nimodipine—CACNA1D—cerebellum—brain cancer	0.00263	0.00684	CbGeAlD
Nimodipine—Vomiting—Lomustine—brain cancer	0.00261	0.00917	CcSEcCtD
Nimodipine—Oedema—Procarbazine—brain cancer	0.0026	0.00916	CcSEcCtD
Nimodipine—Angiopathy—Hydroxyurea—brain cancer	0.00257	0.00905	CcSEcCtD
Nimodipine—Thrombocytopenia—Procarbazine—brain cancer	0.00255	0.00897	CcSEcCtD
Nimodipine—Depression—Carmustine—brain cancer	0.00255	0.00896	CcSEcCtD
Nimodipine—Tachycardia—Procarbazine—brain cancer	0.00254	0.00894	CcSEcCtD
Nimodipine—Hyperhidrosis—Procarbazine—brain cancer	0.00252	0.00886	CcSEcCtD
Nimodipine—NR3C2—endocrine gland—brain cancer	0.00251	0.00652	CbGeAlD
Nimodipine—CACNA1C—central nervous system—brain cancer	0.00248	0.00646	CbGeAlD
Nimodipine—NR3C2—head—brain cancer	0.00248	0.00644	CbGeAlD
Nimodipine—Depression—Temozolomide—brain cancer	0.00246	0.00866	CcSEcCtD
Nimodipine—CACNB2—brain—brain cancer	0.00244	0.00635	CbGeAlD
Nimodipine—Nausea—Lomustine—brain cancer	0.00244	0.00857	CcSEcCtD
Nimodipine—Hypotension—Procarbazine—brain cancer	0.00243	0.00856	CcSEcCtD
Nimodipine—CACNA1C—cerebellum—brain cancer	0.00243	0.00631	CbGeAlD
Nimodipine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00237	0.00835	CcSEcCtD
Nimodipine—Hepatobiliary disease—Temozolomide—brain cancer	0.00233	0.00821	CcSEcCtD
Nimodipine—Cramp muscle—Etoposide—brain cancer	0.00231	0.00812	CcSEcCtD
Nimodipine—Anaemia—Hydroxyurea—brain cancer	0.00228	0.00803	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Etoposide—brain cancer	0.00226	0.00795	CcSEcCtD
Nimodipine—NR3C2—central nervous system—brain cancer	0.00226	0.00588	CbGeAlD
Nimodipine—Hepatitis—Temozolomide—brain cancer	0.00222	0.0078	CcSEcCtD
Nimodipine—NR3C2—cerebellum—brain cancer	0.00221	0.00574	CbGeAlD
Nimodipine—Sweating increased—Etoposide—brain cancer	0.00216	0.00759	CcSEcCtD
Nimodipine—CACNA1D—brain—brain cancer	0.00213	0.00555	CbGeAlD
Nimodipine—Flushing—Carmustine—brain cancer	0.00213	0.00749	CcSEcCtD
Nimodipine—Flushing—Temozolomide—brain cancer	0.00206	0.00724	CcSEcCtD
Nimodipine—Cardiac disorder—Temozolomide—brain cancer	0.00206	0.00724	CcSEcCtD
Nimodipine—Oedema—Hydroxyurea—brain cancer	0.00202	0.00709	CcSEcCtD
Nimodipine—Angiopathy—Temozolomide—brain cancer	0.00201	0.00707	CcSEcCtD
Nimodipine—Immune system disorder—Temozolomide—brain cancer	0.002	0.00704	CcSEcCtD
Nimodipine—Nervous system disorder—Hydroxyurea—brain cancer	0.00198	0.00695	CcSEcCtD
Nimodipine—Thrombocytopenia—Hydroxyurea—brain cancer	0.00197	0.00694	CcSEcCtD
Nimodipine—CACNA1C—brain—brain cancer	0.00197	0.00512	CbGeAlD
Nimodipine—Jaundice—Etoposide—brain cancer	0.00193	0.00677	CcSEcCtD
Nimodipine—Hypersensitivity—Procarbazine—brain cancer	0.00192	0.00675	CcSEcCtD
Nimodipine—Hepatobiliary disease—Etoposide—brain cancer	0.00187	0.00657	CcSEcCtD
Nimodipine—Anaemia—Carmustine—brain cancer	0.00185	0.00649	CcSEcCtD
Nimodipine—Pruritus—Procarbazine—brain cancer	0.00184	0.00648	CcSEcCtD
Nimodipine—Dyspnoea—Hydroxyurea—brain cancer	0.0018	0.00632	CcSEcCtD
Nimodipine—NR3C2—brain—brain cancer	0.00179	0.00466	CbGeAlD
Nimodipine—Anaemia—Temozolomide—brain cancer	0.00178	0.00627	CcSEcCtD
Nimodipine—Diarrhoea—Procarbazine—brain cancer	0.00178	0.00627	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00174	0.00612	CcSEcCtD
Nimodipine—Hypertension—Carmustine—brain cancer	0.00172	0.00606	CcSEcCtD
Nimodipine—Dizziness—Procarbazine—brain cancer	0.00172	0.00606	CcSEcCtD
Nimodipine—Palpitations—Temozolomide—brain cancer	0.0017	0.006	CcSEcCtD
Nimodipine—Myalgia—Carmustine—brain cancer	0.0017	0.00598	CcSEcCtD
Nimodipine—Hypertension—Temozolomide—brain cancer	0.00167	0.00586	CcSEcCtD
Nimodipine—Vomiting—Procarbazine—brain cancer	0.00166	0.00582	CcSEcCtD
Nimodipine—Flushing—Etoposide—brain cancer	0.00165	0.00579	CcSEcCtD
Nimodipine—Cardiac disorder—Etoposide—brain cancer	0.00165	0.00579	CcSEcCtD
Nimodipine—Myalgia—Temozolomide—brain cancer	0.00164	0.00578	CcSEcCtD
Nimodipine—Rash—Procarbazine—brain cancer	0.00164	0.00578	CcSEcCtD
Nimodipine—Dermatitis—Procarbazine—brain cancer	0.00164	0.00577	CcSEcCtD
Nimodipine—Headache—Procarbazine—brain cancer	0.00163	0.00574	CcSEcCtD
Nimodipine—Oedema—Carmustine—brain cancer	0.00163	0.00573	CcSEcCtD
Nimodipine—Angiopathy—Etoposide—brain cancer	0.00161	0.00566	CcSEcCtD
Nimodipine—Immune system disorder—Etoposide—brain cancer	0.0016	0.00563	CcSEcCtD
Nimodipine—Thrombocytopenia—Carmustine—brain cancer	0.0016	0.00561	CcSEcCtD
Nimodipine—Tachycardia—Carmustine—brain cancer	0.00159	0.00559	CcSEcCtD
Nimodipine—Oedema—Temozolomide—brain cancer	0.00157	0.00554	CcSEcCtD
Nimodipine—Nausea—Procarbazine—brain cancer	0.00155	0.00544	CcSEcCtD
Nimodipine—Nervous system disorder—Temozolomide—brain cancer	0.00154	0.00543	CcSEcCtD
Nimodipine—Thrombocytopenia—Temozolomide—brain cancer	0.00154	0.00542	CcSEcCtD
Nimodipine—Hypotension—Carmustine—brain cancer	0.00152	0.00536	CcSEcCtD
Nimodipine—Hyperhidrosis—Temozolomide—brain cancer	0.00152	0.00535	CcSEcCtD
Nimodipine—Hypersensitivity—Hydroxyurea—brain cancer	0.00149	0.00522	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00148	0.00522	CcSEcCtD
Nimodipine—Muscle spasms—Etoposide—brain cancer	0.00148	0.00522	CcSEcCtD
Nimodipine—Dyspnoea—Carmustine—brain cancer	0.00145	0.00511	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00143	0.00505	CcSEcCtD
Nimodipine—Anaemia—Etoposide—brain cancer	0.00143	0.00502	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Carmustine—brain cancer	0.00141	0.00495	CcSEcCtD
Nimodipine—Dyspnoea—Temozolomide—brain cancer	0.0014	0.00494	CcSEcCtD
Nimodipine—Diarrhoea—Hydroxyurea—brain cancer	0.00138	0.00485	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Temozolomide—brain cancer	0.00136	0.00478	CcSEcCtD
Nimodipine—CYP3A5—endocrine gland—brain cancer	0.00136	0.00352	CbGeAlD
Nimodipine—Hypertension—Etoposide—brain cancer	0.00133	0.00469	CcSEcCtD
Nimodipine—Dizziness—Hydroxyurea—brain cancer	0.00133	0.00469	CcSEcCtD
Nimodipine—Vomiting—Hydroxyurea—brain cancer	0.00128	0.00451	CcSEcCtD
Nimodipine—Rash—Hydroxyurea—brain cancer	0.00127	0.00447	CcSEcCtD
Nimodipine—Dermatitis—Hydroxyurea—brain cancer	0.00127	0.00447	CcSEcCtD
Nimodipine—Headache—Hydroxyurea—brain cancer	0.00126	0.00444	CcSEcCtD
Nimodipine—Thrombocytopenia—Etoposide—brain cancer	0.00123	0.00434	CcSEcCtD
Nimodipine—Tachycardia—Etoposide—brain cancer	0.00123	0.00433	CcSEcCtD
Nimodipine—Hyperhidrosis—Etoposide—brain cancer	0.00122	0.00428	CcSEcCtD
Nimodipine—Hypersensitivity—Carmustine—brain cancer	0.0012	0.00422	CcSEcCtD
Nimodipine—Nausea—Hydroxyurea—brain cancer	0.0012	0.00421	CcSEcCtD
Nimodipine—Hypotension—Etoposide—brain cancer	0.00118	0.00414	CcSEcCtD
Nimodipine—Hypersensitivity—Temozolomide—brain cancer	0.00116	0.00408	CcSEcCtD
Nimodipine—Dyspnoea—Etoposide—brain cancer	0.00112	0.00395	CcSEcCtD
Nimodipine—Diarrhoea—Carmustine—brain cancer	0.00111	0.00392	CcSEcCtD
Nimodipine—Pruritus—Temozolomide—brain cancer	0.00111	0.00392	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Etoposide—brain cancer	0.00109	0.00383	CcSEcCtD
Nimodipine—Dizziness—Carmustine—brain cancer	0.00108	0.00379	CcSEcCtD
Nimodipine—Diarrhoea—Temozolomide—brain cancer	0.00108	0.00379	CcSEcCtD
Nimodipine—Dizziness—Temozolomide—brain cancer	0.00104	0.00366	CcSEcCtD
Nimodipine—Vomiting—Carmustine—brain cancer	0.00104	0.00364	CcSEcCtD
Nimodipine—Rash—Carmustine—brain cancer	0.00103	0.00361	CcSEcCtD
Nimodipine—Dermatitis—Carmustine—brain cancer	0.00103	0.00361	CcSEcCtD
Nimodipine—Headache—Carmustine—brain cancer	0.00102	0.00359	CcSEcCtD
Nimodipine—CYP3A4—endocrine gland—brain cancer	0.00102	0.00265	CbGeAlD
Nimodipine—Vomiting—Temozolomide—brain cancer	0.001	0.00352	CcSEcCtD
Nimodipine—Rash—Temozolomide—brain cancer	0.000993	0.00349	CcSEcCtD
Nimodipine—Dermatitis—Temozolomide—brain cancer	0.000992	0.00349	CcSEcCtD
Nimodipine—Headache—Temozolomide—brain cancer	0.000986	0.00347	CcSEcCtD
Nimodipine—Nausea—Carmustine—brain cancer	0.000968	0.0034	CcSEcCtD
Nimodipine—Nausea—Temozolomide—brain cancer	0.000935	0.00329	CcSEcCtD
Nimodipine—Hypersensitivity—Etoposide—brain cancer	0.000928	0.00327	CcSEcCtD
Nimodipine—CYP3A4—central nervous system—brain cancer	0.000916	0.00238	CbGeAlD
Nimodipine—Pruritus—Etoposide—brain cancer	0.000891	0.00314	CcSEcCtD
Nimodipine—Diarrhoea—Etoposide—brain cancer	0.000862	0.00303	CcSEcCtD
Nimodipine—Dizziness—Etoposide—brain cancer	0.000833	0.00293	CcSEcCtD
Nimodipine—Vomiting—Etoposide—brain cancer	0.000801	0.00282	CcSEcCtD
Nimodipine—Rash—Etoposide—brain cancer	0.000794	0.00279	CcSEcCtD
Nimodipine—Dermatitis—Etoposide—brain cancer	0.000794	0.00279	CcSEcCtD
Nimodipine—Headache—Etoposide—brain cancer	0.000789	0.00278	CcSEcCtD
Nimodipine—Nausea—Etoposide—brain cancer	0.000748	0.00263	CcSEcCtD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000425	0.0357	CbGpPWpGaD
Nimodipine—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000421	0.0354	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—NTRK3—brain cancer	0.000408	0.0343	CbGpPWpGaD
Nimodipine—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000405	0.0341	CbGpPWpGaD
Nimodipine—NR3C2—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000367	0.0309	CbGpPWpGaD
Nimodipine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000289	0.0243	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000245	0.0206	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000221	0.0186	CbGpPWpGaD
Nimodipine—CACNA1F—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	0.00021	0.0177	CbGpPWpGaD
Nimodipine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000196	0.0165	CbGpPWpGaD
Nimodipine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000188	0.0158	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000187	0.0158	CbGpPWpGaD
Nimodipine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000175	0.0147	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000174	0.0146	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000173	0.0145	CbGpPWpGaD
Nimodipine—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000172	0.0145	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.00017	0.0143	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000169	0.0142	CbGpPWpGaD
Nimodipine—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000169	0.0142	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—IRS2—brain cancer	0.000155	0.013	CbGpPWpGaD
Nimodipine—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000148	0.0125	CbGpPWpGaD
Nimodipine—CACNB4—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	0.000148	0.0125	CbGpPWpGaD
Nimodipine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000142	0.0119	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—TRPC6—brain cancer	0.000141	0.0118	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—SIRT1—brain cancer	0.000135	0.0114	CbGpPWpGaD
Nimodipine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000134	0.0113	CbGpPWpGaD
Nimodipine—CACNA1F—Alzheimers Disease—TP53—brain cancer	0.000133	0.0112	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000129	0.0108	CbGpPWpGaD
Nimodipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000128	0.0108	CbGpPWpGaD
Nimodipine—CACNB3—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	0.000118	0.00996	CbGpPWpGaD
Nimodipine—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	0.000115	0.00969	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—TRPC6—brain cancer	0.000112	0.00945	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—TRPC6—brain cancer	0.000109	0.0092	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—CDK4—brain cancer	0.000102	0.00862	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TRPC6—brain cancer	0.0001	0.00844	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—CTNNB1—brain cancer	9.28e-05	0.00781	CbGpPWpGaD
Nimodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	8.43e-05	0.00709	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CCND1—brain cancer	8.31e-05	0.00699	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	8.23e-05	0.00693	CbGpPWpGaD
Nimodipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.13e-05	0.00684	CbGpPWpGaD
Nimodipine—AHR—Adipogenesis—STAT3—brain cancer	8.09e-05	0.00681	CbGpPWpGaD
Nimodipine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.02e-05	0.00675	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TRPC6—brain cancer	8.02e-05	0.00675	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—TRPC6—brain cancer	8e-05	0.00674	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TRPC6—brain cancer	7.8e-05	0.00656	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP2C9—brain cancer	7.53e-05	0.00633	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	7.42e-05	0.00625	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	7.24e-05	0.0061	CbGpPWpGaD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	7.23e-05	0.00608	CbGpPWpGaD
Nimodipine—CYP3A4—Irinotecan Pathway—APC—brain cancer	6.9e-05	0.00581	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—TRPC6—brain cancer	6.86e-05	0.00578	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	6.84e-05	0.00576	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MYC—brain cancer	6.67e-05	0.00561	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.59e-05	0.00554	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—EGFR—brain cancer	6.52e-05	0.00549	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—TRPC6—brain cancer	6.5e-05	0.00547	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HES1—brain cancer	6.46e-05	0.00544	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—ESR2—brain cancer	6.34e-05	0.00534	CbGpPWpGaD
Nimodipine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	6.12e-05	0.00515	CbGpPWpGaD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—brain cancer	6.01e-05	0.00506	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—NOTCH2—brain cancer	6.01e-05	0.00506	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP2C9—brain cancer	5.72e-05	0.00481	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TRPC6—brain cancer	5.71e-05	0.00481	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—TRPC6—brain cancer	5.71e-05	0.00481	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—brain cancer	5.47e-05	0.00461	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—brain cancer	5.32e-05	0.00448	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—ERBB2—brain cancer	5.19e-05	0.00437	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HES1—brain cancer	5.17e-05	0.00435	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—CDK4—brain cancer	5.07e-05	0.00427	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HES1—brain cancer	5.02e-05	0.00423	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TRPC6—brain cancer	4.9e-05	0.00412	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—BSG—brain cancer	4.86e-05	0.00409	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TRPC6—brain cancer	4.64e-05	0.0039	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—TP53—brain cancer	4.35e-05	0.00366	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—brain cancer	4.32e-05	0.00364	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—IDH1—brain cancer	4.18e-05	0.00352	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—ERBB2—brain cancer	4.15e-05	0.00349	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TRPC6—brain cancer	4.07e-05	0.00343	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CDK4—brain cancer	4.05e-05	0.00341	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—ERBB2—brain cancer	4.04e-05	0.0034	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—VEGFA—brain cancer	4e-05	0.00336	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CDK4—brain cancer	3.94e-05	0.00332	CbGpPWpGaD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—brain cancer	3.8e-05	0.0032	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—RELA—brain cancer	3.73e-05	0.00314	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—ERBB2—brain cancer	3.7e-05	0.00312	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HES1—brain cancer	3.68e-05	0.0031	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—EGFR—brain cancer	3.6e-05	0.00303	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.5e-05	0.00294	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP2C9—brain cancer	3.49e-05	0.00294	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.45e-05	0.0029	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—DNMT1—brain cancer	3.4e-05	0.00286	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP2C9—brain cancer	3.31e-05	0.00279	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ENO2—brain cancer	3.31e-05	0.00278	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—CTNNB1—brain cancer	3.24e-05	0.00273	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—brain cancer	3.2e-05	0.00269	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HES1—brain cancer	3.16e-05	0.00266	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—VEGFA—brain cancer	3.11e-05	0.00262	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ESR2—brain cancer	3.05e-05	0.00257	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HES1—brain cancer	2.99e-05	0.00252	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—RELA—brain cancer	2.98e-05	0.00251	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—BSG—brain cancer	2.97e-05	0.0025	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—ERBB2—brain cancer	2.96e-05	0.00249	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—ERBB2—brain cancer	2.96e-05	0.00249	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP2C9—brain cancer	2.91e-05	0.00245	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—RELA—brain cancer	2.9e-05	0.00244	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NOTCH2—brain cancer	2.89e-05	0.00243	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CDK4—brain cancer	2.89e-05	0.00243	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ERBB2—brain cancer	2.88e-05	0.00242	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—EGFR—brain cancer	2.88e-05	0.00242	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—brain cancer	2.85e-05	0.0024	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—STAT3—brain cancer	2.82e-05	0.00238	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—BSG—brain cancer	2.81e-05	0.00237	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—brain cancer	2.8e-05	0.00235	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HES1—brain cancer	2.63e-05	0.00221	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CTNNB1—brain cancer	2.59e-05	0.00218	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—brain cancer	2.57e-05	0.00216	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—IDH1—brain cancer	2.56e-05	0.00215	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ERBB2—brain cancer	2.53e-05	0.00213	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CTNNB1—brain cancer	2.52e-05	0.00212	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CDK4—brain cancer	2.47e-05	0.00208	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—BSG—brain cancer	2.47e-05	0.00208	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SIRT1—brain cancer	2.46e-05	0.00207	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—IDH1—brain cancer	2.42e-05	0.00204	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ERBB2—brain cancer	2.4e-05	0.00202	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CDK4—brain cancer	2.34e-05	0.00197	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—brain cancer	2.28e-05	0.00192	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—brain cancer	2.28e-05	0.00192	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—STAT3—brain cancer	2.26e-05	0.0019	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—brain cancer	2.22e-05	0.00187	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—STAT3—brain cancer	2.2e-05	0.00185	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—IDH1—brain cancer	2.13e-05	0.00179	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—RELA—brain cancer	2.12e-05	0.00179	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ERBB2—brain cancer	2.11e-05	0.00178	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ERBB2—brain cancer	2.11e-05	0.00178	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CDK4—brain cancer	2.06e-05	0.00173	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—brain cancer	2.05e-05	0.00173	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—brain cancer	2.05e-05	0.00172	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ENO2—brain cancer	2.02e-05	0.0017	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—brain cancer	2e-05	0.00168	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—brain cancer	2e-05	0.00168	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—brain cancer	1.95e-05	0.00164	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ENO2—brain cancer	1.91e-05	0.00161	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—brain cancer	1.85e-05	0.00156	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CTNNB1—brain cancer	1.85e-05	0.00155	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—RELA—brain cancer	1.82e-05	0.00153	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—brain cancer	1.81e-05	0.00152	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—brain cancer	1.76e-05	0.00148	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RELA—brain cancer	1.72e-05	0.00145	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—brain cancer	1.71e-05	0.00144	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ENO2—brain cancer	1.68e-05	0.00141	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—brain cancer	1.66e-05	0.0014	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—brain cancer	1.63e-05	0.00137	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—brain cancer	1.62e-05	0.00137	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—STAT3—brain cancer	1.61e-05	0.00135	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CTNNB1—brain cancer	1.58e-05	0.00133	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CG—brain cancer	1.52e-05	0.00128	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RELA—brain cancer	1.51e-05	0.00127	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—brain cancer	1.51e-05	0.00127	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CTNNB1—brain cancer	1.5e-05	0.00126	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—brain cancer	1.46e-05	0.00123	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—brain cancer	1.46e-05	0.00123	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—brain cancer	1.39e-05	0.00117	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—STAT3—brain cancer	1.38e-05	0.00116	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—brain cancer	1.32e-05	0.00111	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CTNNB1—brain cancer	1.32e-05	0.00111	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—STAT3—brain cancer	1.31e-05	0.0011	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2C9—brain cancer	1.29e-05	0.00108	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—brain cancer	1.25e-05	0.00106	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—brain cancer	1.19e-05	0.000999	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—brain cancer	1.16e-05	0.000976	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—STAT3—brain cancer	1.15e-05	0.000966	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BSG—brain cancer	1.09e-05	0.000921	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—brain cancer	1.04e-05	0.000878	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—brain cancer	9.64e-06	0.000811	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—IDH1—brain cancer	9.41e-06	0.000792	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CG—brain cancer	9.27e-06	0.00078	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CG—brain cancer	8.77e-06	0.000739	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CG—brain cancer	7.71e-06	0.000649	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO2—brain cancer	7.44e-06	0.000626	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2C9—brain cancer	5.98e-06	0.000504	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BSG—brain cancer	5.09e-06	0.000428	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—IDH1—brain cancer	4.38e-06	0.000368	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO2—brain cancer	3.46e-06	0.000291	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CG—brain cancer	3.41e-06	0.000287	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CG—brain cancer	1.59e-06	0.000134	CbGpPWpGaD
